Delivery Order SPE2DB22D3004-SPE2DB25FRW82
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Pediarix 0.5 ML syringes valued at $7,613.09. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,166.15 firm fixed price delivery order for Pediarix 0.5 mL syringes, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,462.95 to AmerisourceBergen Drug Corp for the supply of Pediarix/PedvaxHIB vaccine vials (0.5 mL) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is listed as the...
- The Defense Logistics Agency awarded a delivery order valued at $3,373.80 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract involves no set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,151.24 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pediarix 0.5 ML syringes. This non-set-aside, firm fixed price contract is classified as a delivery order and has an ultimate completion date of July 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $3,261.55 for Pediarix 0.5 ML syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRW82Delivery Order
The U.S. Defense Logistics Agency awarded a $3,663.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix vaccine vials (0.5mL) on August 7, 2025, with completion expected by August 8, 2025. This is a competitive award with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical and medical supply portfolio supporting Defense Health Agency and military healthcare operations globally. As a major pharmaceutical distributor, the company fulfills critical medical procurement needs through DLA's Medical Supply Chain, delivering vaccines, medications, and medical supplies across multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect routine pharmaceutical delivery operations supporting ongoing military and federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/7/25 |